Clinical Trials Directory

Trials / Completed

CompletedNCT06470334

Dexamethasone With Ropivacaine for PENG Block in Total Hip Arthroplasty

Pericapsular Nerve Group Block With 20 ml 0.2% Ropivacaine vs 10ml 0.2% Ropivacaine and Dexamethasone in Total Hip Arthroplasty: A Randomized Controlled Trial

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Poznan University of Medical Sciences · Academic / Other
Sex
All
Age
65 Years – 100 Years
Healthy volunteers
Not accepted

Summary

Does adding Dexamethasone to the Periarticular Nerve Group Block in Patients undergoing Total Hip Arthroplasty reduce the dose of ropivacaine?

Detailed description

Hip arthroplasty is one of the most common orthopaedic procedures, especially in elderly patients, due to the deformation of joints. Patients may complain of severe pain due to surgical trauma and prostheses. Regional anaesthesia methods may be performed to reduce the inflammatory response, opioid consumption, and opioid-related side effects.

Conditions

Interventions

TypeNameDescription
DRUGRopivacaineUltrasound-guided PENG block - 20ml 0,2% ropivacaine
DRUGRopivacaine+DexamethasoneUltrasound-guided PENG block - 10ml 0,2% ropivacaine + 4mg Dexamethasone

Timeline

Start date
2024-11-07
Primary completion
2025-03-31
Completion
2025-04-30
First posted
2024-06-24
Last updated
2025-07-11

Locations

1 site across 1 country: Poland

Source: ClinicalTrials.gov record NCT06470334. Inclusion in this directory is not an endorsement.